Skip to main content
Explore URMC
URMC / Center for Health + Technology / About Us / Leadership & Faculty


Leadership & Faculty


Chad HeatwoleChad Heatwole, MD, MS-CI
Director, Center for Health + Technology
A neurologist with sub-specialty training in neuromuscular medicine, electrophysiology, and experimental therapeutic development, Dr. Heatwole’s main research focus is the development, evaluation, and testing of novel experimental therapeutics for neuromuscular disease. Under Dr. Heatwole’s leadership, the first/founding institute for outcome measurement for neuromuscular disorders was established at the University of Rochester.


Jamie AdamsJamie Adams, MD
Associate Director, Center for Health + Technology
Dr. Adams is an Associate Professor of Neurology and Movement Disorders specialist at the University of Rochester and Associate Director of the Center for Health + Technology.  Her research focuses on the use and evaluation of digital health technology, such as wearable sensors, smartphone applications, and telemedicine, in individuals with neurodegenerative diseases like Parkinson’s disease and Huntington’s disease.  Incorporating these tools into clinical trials may improve outcome measures and facilitate development of therapeutics.

Ray DorseyRay Dorsey, MD, MBA
David M. Levy Professor of Neurology, Center for Health + Technology
Through novel applications of technology, he and his colleagues seek to enable anyone anywhere to receive care, participate in research, and benefit from therapeutic advances. Dr. Dorsey’s research has been published in leading medical, neurology, and economic journals and has been featured on National Public Radio and in The New York Times and The Wall Street Journal. Disclosures

Cindy CasaceliCynthia Casaceli, MBA
Director, Clinical Trials Coordination Center
Ms. Casaceli leads the University of Rochester’s Clinical Trials Coordination Center and has over 20 years of experience in the operational (project, data and central management) and administrative (contracts, budgets) conduct of an academic research organization. Ms. Casaceli has overseen the conduct and compliance of clinical trials that have led to the FDA approval of seven compounds.

Cornelia KampCornelia Kamp, MBA
Executive Director, Strategic Initiatives, Clinical Materials Services Unit
Ms. Kamp has over 28 years of experience in pharmaceutical based research, both commercial and academic. She established and leads the Clinical Materials Services Unit (CMSU) which provides packaging, labeling, distribution, and return/destructions services for investigational drugs/devices. Ms. Kamp’s research interests include clinical trial design, regulatory aspects of conducting clinical trials, recruitment strategies, and site performance metrics.

Melissa KMelissa Kostrzebski, MS, MBA
Associate Director, Clinical Trials Coordination Center
Ms. Kostrzebski has worked in the healthcare field for over 10 years, having been engaged in clinical research in the fields of breast cancer, surgical oncology and most recently in Parkinson’s disease. Ms. Kostrzebski has managed multi-center clinical trials at the Clinical Trials Coordination Center for the last 5 years. In July of 2021, she assumed the role of the Associate Director of the Clinical Trials Coordination Center. Ms. Kostrzebski holds a master’s in Biology from SUNY Brockport and an MBA from the Simon School at the University of Rochester.

Charles VenutoCharles Venuto, Pharm.D.
Associate Professor, Department of Neurology, Center for Health + Technology
Dr. Venuto is a clinical pharmacologist with expertise in modeling and simulation of drug pharmacokinetics and pharmacodynamics, and disease progression. He founded and leads CHeT Analytics, with the mission to model, predict, and act on data for designing more efficient clinical trials. His research interests are focused on studying the disease progression of neurodegenerative diseases and chronic infectious diseases, and identifying factors underlying disease progression and treatment response heterogeneity.

Charles VenutoChristine Zizzi, MPA
Director, CHeT Health
Ms. Zizzi is a health policy researcher with experience in health policy recommendation and implementation. She brings over 5 years of experience engaging with government and regulatory agencies, non-profits, community organizations, and pharmaceutical companies. Ms. Zizzi founded and leads CHeT Health, which aims to explore the role of health policy in shaping health outcomes, improve understanding of health disparities, advance policies to improve health equity, and augment the involvement of diverse populations during therapeutic trials. She holds a Master in Public Affairs from Princeton University with a certificate in Health and Health Policy.

Renee WilsonRenee Wilson, MA
Director, Project Management
Ms. Wilson has worked in the healthcare field for over 20 years, having been engaged in clinical care and research in the fields of neurology, psychiatry and bioethics. She has held various positions in clinical research for the past 15 years, and for the last 10 years has been managing multi-center clinical trials at the Clinical Trials Coordination Center. Ms. Wilson assumed the role of Director of Project Management in 2019 and holds a MA in Psychology.

Norm YungNorman C. W. Yung, MBA
Director, Operations and Development

Mr. Yung is the Executive Director, Operations & Development, for the Center for Health + Technology. He oversees business development and strategy in the areas of clinical operations and clinical research innovation. Prior to CHeT, Mr. Yung held a number of corporate and consulting positions within the area of health and technology. He holds a Master’s in Business Administration from the Kellogg Graduate School of Management at Northwestern University and a Bachelor’s in Economics from The University of Chicago.

Norm YungJennifer B. Tarolli, JD
Associate Director, CHeT Operations/Legal and Regulatory Liaison
Ms. Tarolli is the Legal Liaison/Regulatory Administrator for the Center for Health + Technology. She oversees and facilitates CHeT agreements for data use and transfer, material transfer, clinical trials, and other matters, as well as supporting and advising on regulatory matters for multi-center clinical trials throughout the Center. Prior to joining CHeT, Ms. Tarolli was in private practice as a litigator focused on the defense of medical malpractice claims, insurance coverage litigation, and various other tort and commercial matters. She received her JD from Brooklyn Law School and a Bachelor’s degree in political science from Syracuse University.




Jamie Adams, MD
Assistant Professor of Neurology

Alicia Augustine, PhD
Adjunct Assistant Professor of Neurology

Erika Augustine, MD, MS
Adjunct Professor of Neurology and Pediatrics

Peggy Auinger, MS
Associate, Department of Neurology

Kevin Biglan, MD, MPH
Professor of Neurology

Gretchen Birbeck, M.D., M.P.H.
Professor of Neurology

Cynthia Casaceli, MBA
Senior Associate, Department of Neurology

Ray Dorsey, MD, MBA
David M. Levy Professor of Neurology

Robert Dworkin, PhD
Professor of Anesthesiology, Neurology, Oncology, and Psychiatry

Robert C. Griggs, MD
Professor of Neurology, Medicine, Pathology and Laboratory Medicine, and Pediatrics

Chad Heatwole, MD, MS-CI
Professor of Neurology


Monica Javidnia, PhD
Adjunct Instructor, Department of Neurology

Cornelia Kamp, MBA
Senior Associate, Department of Neurology

Elise Kayson, MS, RNC, ANP
Adjunct Instructor, Department of Neurology

Karl Kieburtz, MD, MPH
Professor of Neurology

Benzi Kluger, MD, MS
Professor of Neurology
Director, Center for Palliative Care
Chief, Division of Neuropalliative Care

Melissa Kostrzebski, MS, MBA
Associate, Department of Neurology 

Michael P. McDermott, PhD
Professor of Biostatistics and Neurology

Oing Ma, PhD
Research Assistant Professor of Pharmacology and Physiology

Gene D. Morse, PharmD
Professor of Pharmacy Practice, Medicine, and Pediatrics, University at Buffalo

Charles Venuto, PharmD
Assistant Professor of Neurology

Christine Zizzi, MPA
Associate, Department of Neurology